Axonics Modulation Technologies, Inc. AXNX was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up 14.3% in the past one-month time frame.
The company has seen three negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
Axonics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Axonics Modulation Technologies, Inc. Price
Axonics Modulation Technologies, Inc. price | Axonics Modulation Technologies, Inc. Quote
Another stock in the Medical sector is Anavex Life Sciences Corp. AVXL, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report
Axonics Modulation Technologies, Inc. (AXNX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research